Effectiveness and Safety of Switching from Innovator...

  • Main
  • 2017 / 6
  • Effectiveness and Safety of Switching from Innovator...
Drugs in R & D 2017 / 6

Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study

Vergara-Dangond, Cristina, Sáez Belló, Marina, Climente Martí, Mónica, Llopis Salvia, Pilar, Alegre-Sancho, Juan José
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Drugs in R&D
DOI:
10.1007/s40268-017-0194-8
Date:
June, 2017
File:
PDF, 492 KB
english, 2017
Conversion to is in progress
Conversion to is failed